Wound Care Biologics Market
According to Intent Market Research, the Wound Care Biologics Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 9.1% to touch USD 4.3 billion by 2030. The Wound Care Biologics Market is dominated by key players such as Smith & Nephew, M–lnlycke Health Care, Integra LifeSciences Corporation, Acelity Inc., ConvaTec Group, Organogenesis Inc., AlloSource, B. Braun Melsungen AG, Medtronic PLC, Derma Sciences, Inc., Celltex Therapeutics Corporation, Advanced BioHealing, Inc. and Human Biosciences, Inc.